Voliotis Dimitris
SEC CIK 1807910 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | SVP, Clinical Development | 16.0K | — | $1.87M | 4 | 2022-01-18 | 2022-02-14 |
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Voliotis Dimitris made no open-market trades at ZNTL in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-14 | 2022-02-14 | ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | S - Sale | $50.23 | -601 | 16.0K | -4% | -$30.2K |
| D | 2022-02-14 | 2022-02-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | A - Grant | $0.00 | +10.3K | 16.6K | +165% | $0 |
| DM | 2022-01-20 | 2022-01-18+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | S - Sale+OE | $61.36 | -30.0K | 7,550 | -80% | -$1.84M |
| DM | 2022-01-20 | 2022-01-18+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | M - OptEx | $18.00 | +30.0K | 16.2K | New | +$540.0K |
Purchase Sale Sale after option exercise All abbreviations